Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream
Status:
Completed
Trial end date:
2021-07-30
Target enrollment:
Participant gender:
Summary
Participants will have study medicine applied by site staff- delgocitinib cream or vehicle,
and then exposed to UV light. The trial is designed to find out if delgocitinib cream can
cause skin photoallergy after UV-light exposure in people with healthy skin.